Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer - Concepedia

Concepedia

Publication | Closed Access

Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer

29

Citations

24

References

2014

Year

Hiroaki Ikesue, Toshikazu Tsuji, Koujiro Hata, Hiroyuki Watanabe, Kazuto Mishima, Mayako Uchida, Nobuaki Egashira, Toshihiro Miyamoto, Eishi Baba, Koichi Akashi,

Annals of Pharmacotherapy

Abstract

Our results support more frequent monitoring of serum calcium concentrations at baseline and during the first 2 weeks of treatment in patients receiving denosumab, especially those with an eGFR <30 mL/min.

References

	Year	Citations

Page 1